Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis-Reference-Cited by-同舟云学术

Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis

Published:2006-09-15 Issue:9 Volume:2 Page:e92
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Debrah Alexander Yaw,Mand Sabine,Specht Sabine,Marfo-Debrekyei Yeboah,Batsa Linda,Pfarr Kenneth,Larbi John,Lawson Bernard,Taylor Mark,Adjei Ohene,Hoerauf Achim

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference85 articles.

1. World Health Organization 2005 WHO annual report on lymphatic filariasis 2004 Available: http://www.filariasis.org. Accessed 12 October 2005.

2. Elimination of lymphatic filariasis as a public health problem.;Parasitol Today,2000

3. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo.;Trans R Soc Trop Med Hyg,1997

4. Mass treatment to eliminate filariasis in Papua New Guinea.;N Engl J Med,2002

5. Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: Follow-up at 10 years after treatment.;Trans R Soc Trop Med Hyg,2004

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND);Frontiers in Pharmacology;2024-09-04

2. The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis;Trends in Parasitology;2024-09

3. A Landscape on Lymphatic Filariasis with its Effects and Recent Advanced Treatments;Recent Advances in Anti-Infective Drug Discovery;2024-08

4. Vascular Endothelial Growth Factor C (VEGF-C) Sensitizes Lymphatic Endothelial Cells to Oxidative-Stress-Induced Apoptosis through DNA Damage and Mitochondrial Dysfunction: Implications for Lymphedema;International Journal of Molecular Sciences;2024-07-17

5. A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti‐Wolbachia Candidate Macrofilaricide;Clinical Pharmacology in Drug Development;2024-06-24